Failure of systemic empirical treatment with amphotericin B to prevent candidemia in neutropenic patients with cancer

Clinical Infectious Diseases

Volumn 22, Issue 3, 1996, Pages 462-466

  Blumberg, Emily A ^a,c   Reboli, Annette C ^a,b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c HAHNEMANN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMSACRINE; CYTARABINE; NYSTATIN;

ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANDIDIASIS; CASE REPORT; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HOST SUSCEPTIBILITY; HUMAN; INFECTION PREVENTION; INFECTION SENSITIVITY; NEUTROPENIA; PRIORITY JOURNAL; SPLENECTOMY; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; AGED; AMPHOTERICIN B; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS; FATAL OUTCOME; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; NEUTROPENIA; RETROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 0030059655     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/22.3.462     Document Type: Article

References (20)

1. DeGregorio MW, Lee WM, Linker CA, Jacobs RA, Reis CA. Fungal infections in patients with acute leukemia. Am J Med 1982;73:543-8.
2. Meyers JD. Fungal infections in bone marrow transplant patients. Sem Oncol 1990;17(suppl 6):10-3.
3. Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 1982;72:101-11.
4. Whimbey E, Kiehn TE, Brannon P, Blevins A, Armstrong D. Bacteremia and fungemia in patients with neoplastic disease. Am J Med 1987;82:723-30.
5. Winston DJ, Chandrasekar PH, Lazarus HM, et al. Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial. Ann Intern Med 1993;118:495-503.
6. Bodey GP, Anaissie EJ, Elting LS, Estey E, O'Brien S, Kantarjian H. Antifungal prophylaxis during remission induction therapy for acute leukemia. Fluconazole versus intravenous amphotericin B. Cancer 1994;73:2099-106.
7. Perfect JR, Klotman ME, Gilbert CC, et al. Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients. J Infect Dis 1992;165:891-7.
8. Riley DK, Pavia AT, Beatty PG. Prophylactic use of low-dose amphotericin B in bone marrow transplant patients. Am J Med 1994;97:509-14.
9. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991;325:1274-7.
10. Jakab K, Kelemen E, Prinz G, Török I. Amphotericin-resistant invasive hepatosplenic candidiasis controlled by fluconazole. Lancet 1990;335:473-4.
11. EORTC International Antimicrobial Therapy Cooperative Group. Empiric antifungal therapy in febrile granulocytopenic patients. Am J Med 1989;86:668-72.
12. Powderly WG, Kobayashi GS, Herzig GP, Medoff G. Amphotericin B-resistant yeast infection in severely immunocompromised patients. Am J Med 1988;84:826-32.
13. Dick JD, Rosengard BR, Merz WG, Stuart RK, Hutchins GM, Saral R. Fatal disseminated candidiasis due to amphotericin B-resistant Candida guilliermondii. Ann Intern Med 1985;102:67-8.
14. Merz WG, Karp JE, Schron D, Saral R. Increased incidence of fungemia caused by Candida krusei. J Clin Microbiol 1986;24:581-4.
15. National Committee for Clinical Laboratory Standards. Antifungal susceptibility testing: committee report. NCCLS publication no M27-P. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1992.
16. DeGregorio MW, Lee WMF, Ries CA. Candida infections in patients with acute leukemia: ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis. Cancer 1982;50:2780-4.
17. Lecciones JA, Lee JW, Navarro EE, et al. Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis 1992;14:875-83.
18. Lowder JN, Lazarus HM, Herzig RH. Bacteremias and fungemias in oncologic patients with central venous catheters. Arch Intern Med 1982;142:1456-9.
19. Odds FC, Kibbler CC, Walker E, Bhamra A, Prentice HG, Noone P. Carriage of Candida species and C. albicans biotypes in patients undergoing chemotherapy or bone marrow transplantation for haematological disease. J Clin Pathol 1989;42:1259-66.
20. Sandford GR, Merz WG, Wingard JR, Charache P, Saral R. The value of fungal surveillance cultures as predictors of systemic fungal infections. J Infect Dis 1980;142:503-9.